Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2019.10.004
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2020
Authors
Publisher
Elsevier BV